Unlike other more common forms of melanoma, AMs occur in all ethnic groups.
Acral melanoma (AM) is the least common of four subtypes of cutaneous melanoma (approximately 2% to 10% of all melanoma cases). It is however, the most common cutaneous melanoma in dark-skinned patients. To characterize factors associated with the poor survival outcomes in patients with AM, investigators at a single cancer center compared 281 patients with AM and 843 patients with other nonacral cutaneous melanomas (NACMs) of the extremities (14% and 0% nonwhite, respectively).
The 5-year survival rate was 70% in AM patients and 83% in NACM patients. Breslow thickness, Clark level, positive margin status, sentinel lymph node (SLN) positivity, higher pathologic stage, and ulceration were all significantly associated with reduced disease-speci…
Reviewing Author
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)